Figure 5.
Receiver operating characteristic analysis for discriminating participants with and those without sarcopenia by (A) tumor necrotizing factor (TNF)-α, (B) interleukin (IL)-1β, (C) IL-6, and (D) IL-15.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.